Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02336308Phase 4Withdrawn
Phase 4, randomised, double-blind trial in anxiety disorder, acute stress disorder (ASD), post-traumatic stress disorder (PTSD) and 1 more comparing Ketamine Arm with Placebo Arm (2 arms). Primary endpoints: Opioid requirements surrounding dressing changes at 4 hours, Benzodiazepine requirements surrounding dressing changes at 4 hours and 1 more. Planned start Jan 2015; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02336308.